Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

17.2K
The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...
17.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-assisted image analysis of tumor-infiltrating lymphocytes as a prognostic marker in chemotherapy-naïve luminal breast cancer.

NPJ breast cancer·2026
Same author

dMMR prediction from colorectal cancer histopathology: Leveraging non-tumor and low-magnification regions.

Computer methods and programs in biomedicine·2026
Same author

SparStVR - exploring sparse 3D histology data in virtual reality.

Communications engineering·2026
Same author

Staining normalization in histopathology: Method benchmarking using multicenter dataset.

Scientific reports·2026
Same author

Canine parvovirus infection affects host cell nucleolar organization and ribosome biogenesis.

Communications biology·2026
Same author

Validation of a deep learning-based AI model for breast cancer risk stratification in postmenopausal ER+/HER2-breast cancer patients.

Breast (Edinburgh, Scotland)·2025

Related Experiment Video

Updated: Mar 22, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K

Flow Cytometry-Based Classification in Cancer Research: A View on Feature Selection.

S Sakira Hassan1, Pekka Ruusuvuori2, Leena Latonen3

  • 1Department of Signal Processing, Tampere University of Technology, Tampere, Finland.

Cancer Informatics
|April 16, 2016
PubMed
Summary

This study demonstrates that up to 50% of features can be removed in cancer machine learning tasks without impacting prediction accuracy, even with limited data. It also compares cross-validation with a Bayesian error estimator for model selection.

Keywords:
AMLerror estimationflow cytometryleukemialogistic regressionmodel selection

More Related Videos

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

6.0K
Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore
06:01

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore

Published on: December 12, 2019

9.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.5K
Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

6.0K
Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore
06:01

Visualization and Quantification of High-Dimensional Cytometry Data using Cytofast and the Upstream Clustering Methods FlowSOM and Cytosplore

Published on: December 12, 2019

9.0K

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Machine Learning

Background:

  • Machine learning models are increasingly used for cancer detection and prediction.
  • Effective feature selection is crucial for building accurate and stable models, especially with limited sample sizes.
  • Previous research indicated high accuracy with sufficient data, but reliability with small datasets remains a challenge.

Purpose of the Study:

  • To evaluate feature selection methods for cancer-related machine learning tasks using simplified pipelines.
  • To identify reliable feature selection approaches for extremely small sample sizes.
  • To compare traditional cross-validation with a Bayesian error estimator for model selection in logistic regression.

Main Methods:

  • Investigated the accuracy and stability of various feature selection techniques.
  • Utilized simplistic machine learning pipelines to focus on feature selection performance.
  • Compared cross-validation and a Bayesian error estimator for model selection within the ℓ 1 regularization path of logistic regression classifiers.

Main Results:

  • Demonstrated that up to 50% of features can be discarded without compromising prediction accuracy.
  • Showcased the reliability of certain feature selection approaches even with extremely small sample sizes.
  • Found comparable performance between cross-validation and the Bayesian error estimator in specific model selection scenarios.

Conclusions:

  • Feature selection is robust in cancer machine learning, allowing significant data reduction without accuracy loss.
  • The findings support the use of simplified models and effective feature selection for reliable cancer prediction with limited data.
  • Both cross-validation and Bayesian error estimation are viable for model selection, offering flexibility in pipeline design.